242653 ⎘
Compounds as L-cystine crystallization inhibitors and uses thereof
#2Compounds as L-cystine crystallization inhibitors and uses thereof
#3Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes
#4USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA
#5USE OF RARE EARTH COMPOUNDS FOR THE PREVENTION OF KIDNEY STONE DISEASE
#6Methods and devices for the in situ dissolution of renal calculi
#7Methods and devices for the in situ dissolution of renal calculi
#8Preventives and/or remedies for hyperphosphatemia
#9Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia